Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C390307-100 100 µg (1 mg/ml) $574 
Antibody

Monoclonal Mouse anti‑Human HLA‑A Antibody (clone 108‑2C5, Azide‑free,BSA‑free, IF) LS‑C390307

Monoclonal Mouse anti‑Human HLA‑A Antibody (clone 108‑2C5, Azide‑free,BSA‑free, IF) LS‑C390307

Antibody:
HLA-A Mouse anti-Human Monoclonal (Azide-free, BSA-free) (108-2C5) Antibody
Application:
IF, Flo
Reactivity:
Human
Format:
Unconjugated, Azide-free, BSA-free
Other formats:
Price
Catalog Number
$574
LS-C390307-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
HLA-A Mouse anti-Human Monoclonal (Azide-free, BSA-free) (108-2C5) Antibody
Application:
IF, Flo
Reactivity:
Human
Format:
Unconjugated, Azide-free, BSA-free
Other formats:

Specifications

Description
HLA-A antibody LS-C390307 is an unconjugated mouse monoclonal antibody to human HLA-A. Validated for Flow and IF.
Target
Human HLA-A
Synonyms
HLA-A | Leukocyte antigen class I-A | HLAA | HLA class I histocompatibility antigen, A-1 alpha chain
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1,k Monoclonal
Clone
108-2C5
Conjugations
Unconjugated
Purification
Protein G purified
Modifications
Azide-free, BSA-free. Also available Unmodified.
Immunogen
Normal human peripheral blood lymphocytes were used as the immunogen for the HLA-A antibody.
Specificity
Human HLA-A
Applications
  • Immunofluorescence (0.5 - 1 µg/ml)
  • Flow Cytometry (0.5 - 1 µg/10E6 cells)
Usage
The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. HLA-A, with HLA-B and HLA-C, belongs to major histocompatibility complex (MHC) class I antigens and expresses constitutively on all nucleated cells. MHC class I antigens play a role in class I MHC-associated antigen presentation, inhibition of NK cell cytotoxicity, tumor surveillance, and tissue allotransplantation. This mAb is useful for HLA molecular typing of peripheral blood leukocytes as well as a large number of leukemic cell lines. It reacts with an intralocus determinant present on a limited number of HLA-A locus-encoded gene products (HLA-A2, -A3, -A28, -A29, -A30, -A31 and Aw33). Its epitope maps between aa65-to-aa80 of the alpha1 domain of the HLA-A. This mAb recognizes an intralocus determinant present on a limited number of HLA-A locus-encoded gene products (HLA-A2, -A3, A28, -A29, -A30, -A31 and -Aw33). Furthermore, by testing its reactivity with HLA-A2 natural variants and mutants, the importance of amino acid residues 79 and/or 80 of the alpha1 domain was demonstrated in the formation of an intralocus HLA-A determinant. Optimal dilution of the HLA-A antibody should be determined by the researcher.
Presentation
1X PBS
Storage
Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About HLA-A
P04439 NM_002116 NP_002107.3

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/19/2024